Results 21 to 30 of about 49,177 (212)

Tardive Dyskinesia [PDF]

Schizophrenia Bulletin, 1993
Neuroleptic-induced tardive dyskinesia (TD) continues to be a serious problem in the psychopharmacology of schizophrenia. The overall mean prevalence of TD among chronically neuroleptic-treated patients is approximately 24 percent. The annual incidence in younger adults is 4 to 5 percent. Aging is a major risk factor for TD.
D V, Jeste, M P, Caligiuri
openaire   +2 more sources

Tardive dyskinesia: apropos of a case. This is a case related to drug side effects, whose uniqueness lies in the time of onset of symptoms, Tardive dyskinesia is a drug-induced hyperkinetic movement disorder.

European Psychiatry, 2023
Introduction Tardive dyskinesia is finally diagnosed, it is a drug-induced hyperkinetic movement disorder associated with the use of dopamine receptor blocking agents, including first and second generation antipsychotic drugs, metoclopramide and ...
R. F. Díaz
doaj   +1 more source

The use of clozapine and clonazepam co-administration in the treatment of a severe tardive dyskinesia: A case report

SAGE Open Medical Case Reports, 2019
This is a case report of a patient who was treated with clozapine and clonazepam after he developed neuroleptic-induced tardive dyskinesia following treatment for schizophrenia.
Kibrom Haile, Halima Umer
doaj   +1 more source

TARDIVE DYSKINESIA AND SUPERSENSITIVITY PSYCHOSIS DUE TO ATYPICAL ANTIPSYCHOTICS: A CASE REPORT

Psychiatry and Clinical Psychopharmacology, 2021
Tardive dyskinesia emerges in the patient predisposed to the condition as a result of using long term antipsychotics. The usage of classical antipsychotics increase the risk of tardive dyskinesia.
Ali Çayköylü, Nazan Aydın, Filiz Karalar   +2 more
doaj  

Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations

SAGE Open Medicine, 2016
Objectives: An established theory for the pathogenesis of tardive dyskinesia is disturbed dopaminergic receptor sensitivity and/or dopaminergic intracellular signaling.
Svetlana A Ivanova, Anton JM Loonen, P Roberto Bakker, Maxim B Freidin, Nienke J ter Woerds, Asmar FY Al Hadithy, Arkadiy V Semke, Olga Yu Fedorenko, Jacobus RBJ Brouwers, Nikolay A Bokhan, Jim van Os, Peter N van Harten, Bob Wilffert   +12 more
doaj   +1 more source

An investigation on the relationship between risk factors and severity of tardive dyskinesia [PDF]

Journal of Kerman University of Medical Sciences, 1993
The focus of most previous research concerning tardive dyskinesia has been on the impact of risk factors on the development( incidence) of this syndrome.
Y Kalafi, GH.R Tadayoni
doaj  

Improvement of Tardive Dyskinesia during Mindfulness Meditation

Neurology International, 2021
Background: We report the case of a patient presenting with orofacial tardive dyskinesia (TD), following administration of a first-generation antipsychotic (Loxapine).
Maria Angela Santoro, Isolde English, Idil Sezer, Mickael Amagat, Frank Ly, Edouard Chaneac, Patricia Cailliez, Hugo Bottemanne   +7 more
doaj   +1 more source

Tardive Dystonia: Clinical Spectrum and Novel Manifestations

Behavioural Neurology, 1988
Tardive dystonia was identified in 25 patients: involvement of the face and neck was most common; truncal and limb dystonia were also observed. There were 3 cases of laryngospasm and 2 of spasmodic dysphonia.
R. Jeffrey Davis, Jeffrey L. Cummings, Robert W. Hierholzer   +2 more
doaj   +1 more source

Risperidone induced tardive movements in an elderly male-a case of cognitive decline masked by behavioral abnormalities

Geriatric Care, 2022
Tardive dyskinesia is a drug emergent side effect associated with long-term exposure to neuroleptics. Risperidone has lesser propensity to cause tardive movements. A 67-year-old male presented with tardive symptoms.
Vishnupriya Veeraraghavan, Dinesh Agarwal   +1 more
doaj   +1 more source

A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution

Case Reports in Psychiatry, 2016
Aripiprazole is reported to be a good clinical safety profile antipsychotic. However, recent data suggest that the risk of tardive dyskinesia could be higher than initially thought.
Edwige Heitzmann, Hervé Javelot, Luisa Weiner, Bruno Michel   +3 more
doaj   +1 more source